VERACYTE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
VERACYTE, INC. (VCYT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $5.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-02-26
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $5.40M, a 44.90% decline from fiscal 2024.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $9.80M, a 20.99% increase from fiscal 2023.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $8.10M, a 19.12% increase from fiscal 2022.
- VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $6.80M, a 12.82% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|
| 2025-12-31 | $5.40M 10-K · filed 2026-02-26 |
| 2024-12-31 | $9.80M 10-K · filed 2026-02-26 |
| 2023-12-31 | $8.10M 10-K · filed 2026-02-26 |
| 2022-12-31 | $6.80M 10-K · filed 2025-02-28 |
| 2021-12-31 | $7.80M 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |